Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.885 USD | -1.28% | -11.24% | +9.29% |
01:15am | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- IOVA Stock
- Revisions Iovance Biotherapeutics, Inc.